As the number of pre- and post-transplant solid organ recipients continues to grow, it becomes important for all physicians to have an understanding of the process of organ procurement and allocation. In the United States, the current system for allocation and transplantation of human solid organs has been heavily influenced by the experience in deceased donor liver transplantation (DDLT). This review highlights the significant changes that have occurred over the past 10 years in DDLT, with specific attention to the impact of the Model for Endstage Liver Disease (MELD) score on organ allocation and pre- and post-transplant survival. DDLT is managed by the United Network for Organ Sharing (UNOS) which oversees organ procurement and allocatio...
BACKGROUND & AIMS: An optimal allocation system for scarce resources should simultaneously ensure ma...
In 2009, almost 1,500 Americans died of end-stage liver disease (ESLD), which is the twelfth leading...
Introduction. Model for end-stage liver disease (MELD) is an accurate predictor of mortality in pati...
The widespread recognition of the success of liver transplantation as a treatment for most types of ...
Since February 2002, the United Network for Organ Sharing (UNOS) proposed to adopt a modified versio...
Liver transplantation has become the mainstay for the treatment of end-stage liver disease, hepatoce...
Since its evolution, organ allocation in liver transplantation has been based upon the ‘rule of resc...
Copyright © 2012 Markus Quante et al. This is an open access article distributed under the Creative ...
On June 18, 2013, the organ procurement and transplant network (OPTN) implemented the, “Share-35” sc...
We analyzed the first 100 patients who underwent liver transplantation by Model for End-Stage Liver ...
Background: Organ allocation in multivisceral transplant (MVT; liver-intestine, liver-pancreas-intes...
The Model for End-Stage Liver Disease (MELD) score has been successfully used to prioritize patients...
Adoption of the Model for End-stage Liver Disease (MELD) to select and prioritize patients for liver...
The Model for End-Stage Liver Disease (MELD)-based allocation system was implemented in Germany in 2...
BACKGROUND: In June 2016, the Korean Network for Organ Sharing implemented a Model for End-stage...
BACKGROUND & AIMS: An optimal allocation system for scarce resources should simultaneously ensure ma...
In 2009, almost 1,500 Americans died of end-stage liver disease (ESLD), which is the twelfth leading...
Introduction. Model for end-stage liver disease (MELD) is an accurate predictor of mortality in pati...
The widespread recognition of the success of liver transplantation as a treatment for most types of ...
Since February 2002, the United Network for Organ Sharing (UNOS) proposed to adopt a modified versio...
Liver transplantation has become the mainstay for the treatment of end-stage liver disease, hepatoce...
Since its evolution, organ allocation in liver transplantation has been based upon the ‘rule of resc...
Copyright © 2012 Markus Quante et al. This is an open access article distributed under the Creative ...
On June 18, 2013, the organ procurement and transplant network (OPTN) implemented the, “Share-35” sc...
We analyzed the first 100 patients who underwent liver transplantation by Model for End-Stage Liver ...
Background: Organ allocation in multivisceral transplant (MVT; liver-intestine, liver-pancreas-intes...
The Model for End-Stage Liver Disease (MELD) score has been successfully used to prioritize patients...
Adoption of the Model for End-stage Liver Disease (MELD) to select and prioritize patients for liver...
The Model for End-Stage Liver Disease (MELD)-based allocation system was implemented in Germany in 2...
BACKGROUND: In June 2016, the Korean Network for Organ Sharing implemented a Model for End-stage...
BACKGROUND & AIMS: An optimal allocation system for scarce resources should simultaneously ensure ma...
In 2009, almost 1,500 Americans died of end-stage liver disease (ESLD), which is the twelfth leading...
Introduction. Model for end-stage liver disease (MELD) is an accurate predictor of mortality in pati...